https://scholars.lib.ntu.edu.tw/handle/123456789/183796
標題: | Avidity of CD1d-ligand-receptor ternary complex contributes to T-helper 1 (Th1) polarization and anticancer efficacy | 作者: | Wu, Tai-Na Lin, Kun-Hsien Chang, Ya-Jen Huang, Jing-Rong Cheng, Jing-Yan Yu, Alice L. Wong, Chi-Huey |
關鍵字: | Cancer immunotherapy; Immune-modulating activity; Interaction; Structure | 公開日期: | 2011 | 起(迄)頁: | 17275-17280 | 來源出版物: | Proceedings of the National Academy of Sciences | 摘要: | Invariant natural killer T cell (NKT) cells (iNKT cells) produce both T-helper 1 (Th1) and T-helper 2 cytokines in response to α- Galactosylceramide (α-GalCer) stimulation and are thought to be the important effectors in the regulation of both innate and adaptive immunity involved in autoimmune disorders, microbial infections, and cancers. However, the anticancer effects of α-GalCer were limited in early clinical trial. In this study, several analogs of α-GalCer, containing phenyl groups in the lipid tails were found to stimulate murine and human iNKT cells to secrete Th1-skewed cytokines and exhibit greater anticancer efficacy in mice than α-GalCer. We explored the possibility of different Vβ usages of murine Vα14 iNKT or human Vα24 iNKT cells, accounting for differential cytokine responses. However, T-cell receptor Vβ analysis revealed no significant differences in Vβ usages by α-GalCer and these phenyl glycolipid analogs. On the other hand, these phenyl glycolipids showed greater binding avidity and stability for iNKT T-cell receptor when complexed with CD1d. These findings suggest that CD1d-phenyl glycolipid complexes may interact with the same population of iNKT cells but with higher avidity and stability to drive Th1 polarization. Thus, this study provides a key to the rational design of Th1 biased CD1d reactive glycolipids in the future. |
URI: | http://ntur.lib.ntu.edu.tw//handle/246246/239062 | DOI: | 10.1073/pnas.1114255108 | SDG/關鍵字: | alpha galactosylceramide; CD1d antigen; T lymphocyte receptor beta chain; ternary complex factor; antineoplastic activity; article; binding affinity; cancer growth; cell polarity; chemical structure; controlled study; cytokine production; cytokine response; human; human cell; immunomodulation; in vitro study; in vivo study; mouse; natural killer cell; nonhuman; priority journal; Th1 cell; Th2 cell; Animals; Antigens, CD1d; Cell Line, Tumor; Chemokines; Cytokines; Female; Galactosylceramides; Glycolipids; Humans; Immunotherapy; Ligands; Lymphocyte Activation; Macromolecular Substances; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Natural Killer T-Cells; Neoplasms, Experimental; Receptors, Antigen, T-Cell, alpha-beta; Th1 Cells; Murinae; Mus |
顯示於: | 化學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。